GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Indoco Remedies INDOCO.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

219.34

+1.99%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

9 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 0Strong buy
  • 1Buy
  • 4Hold
  • 2Sell
  • 2Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Last close 219.34Average target 264.44

Low
226.24
Average
264.44
Median
261.63
High
315.00

Forecasts

Analyst averages for the fiscal years ahead

FY2027FY2028FY2029
Revenue₹20.38bn₹23.06bn₹28.05bn
Revenue, highest₹21.16bn₹24.36bn₹30.37bn
Revenue, lowest₹19.47bn₹21.86bn₹25.74bn
Earnings per share6.5811.1520.40
Earnings per share, highest25.3614.3824.27
Earnings per share, lowest-13.157.4116.53
Analysts442

Earnings against forecasts

Earnings per share by fiscal quarter

Q1 2026Q3 2026Q2 2026Q2 2025Q4 2025Q4 2024Q3 2025Q1 2024
Forecast-3.550.40-0.91-3.00-3.64-1.50-2.422.80
Reported-2.30-3.20-1.07-3.94-4.48-3.05-2.960.31
Difference+35.2%-892.1%-17.7%-31.3%-23.2%-103.3%-22.1%-88.9%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

2 / 10

Revenue growth 6.3% a year over 10 years. Return on equity -10.5%.

Model fair value

241.40

From earnings 241.40, from revenue 284.84.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.